CYBREX TOBRAMYCIN— 510(k) K802668

Substantially Equivalent

Abbott Laboratories

FDA 510(k) clearance K802668 for CYBREX TOBRAMYCIN, Substantially Equivalent on 1980-11-24. Applicant: Abbott Laboratories.

Clearance details

Applicant
Abbott Laboratories
Product code
Code LCR
Advisory panel
Clinical Toxicology
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Abbott Park, IL, US
Download summary PDFView on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.